Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.56
+0.07 (0.25%)
At close: Feb 18, 2026, 4:00 PM EST
27.50
-0.06 (-0.22%)
After-hours: Feb 18, 2026, 5:42 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Genetic Medicines
63.52M
Genetic Medicines Growth
-83.18%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
63.52M
United States Growth
-83.18%